HFGF Digital Forum – 10th edition
A hybrid Forum
Monday 10th Oct. 2022
Tuesday 11th Oct. 2022
Thursday 17th Nov. 2022
This event has been submitted to Medtech with reference number EMT29281 and is in review.
4 Half days of interactive discussions
Monday 10th October 2022
Tuesday 11th October 2022
Thursday 17th November 2022
The Heart Failure Guidelines Forum is a close meeting gathering experts and pharmaceutical industries to discuss the heart failure guidelines process and its implications.
This year, TMA organizes 3 half days of interactive discussions on heart failure and invites you to a new experience for this 10th edition.
ORGANIZATION
Charles Schoen – Operations Director
Tel.: +33 (0) 6 08 18 77 08
Email: charles.schoen@tmacademy.org
REGISTRATION & SPONSORSHIP
Fabrice Poller
Tel: +33 (0) 6 99 66 19 73
Email: fpoller@tmacademy.org
BETTER UNDERSTAND THE HEART FAILURE GUIDELINES PROCESS AND ITS IMPLICATIONS
AN OPPORTUNITY TO MEET A PANEL OF INTERNATIONAL EXPERTS IN HEART FAILURE
Why attend a Guidelines
Forum on heart failure?
The quality of research and development efforts made by manufacturers of pharmacological agents, biomarkers, and medical devices has obviously had a major impact on the position of these products in clinical guidelines on the management of heart failure.
Conversely, the release of new guidelines may be a source of inspiration for further research and development. And, ultimately, guidelines really shape clinical practice if doctors and their patients adopt them.
A better understanding of the processes involved in guidelines development will help companies that develop drugs, biomarkers, and devices to adapt and improve their research and development programmes for the future.
This could also translate into earlier and more efficient development of diagnostic and therapeutic tools for patients.
Why may guidelines of geographically distinct origins but dealing with the same evidence occasionally reach different conclusions? What should be done to avoid that guidelines being lost in translation? How can we adapt the guidelines for low and middle income countries?
Speakers and discussants who will address these topics have been selected from among the top-level European, North American and international experts in cardiology who participate in the regular update of guidelines. The faculty also comprises clinicians with a strong interest in translational and patient-centered medicine.
The Heart Failure Guidelines Close Forum will be strictly academic – meaning that attendees will not participate during the main sessions and discussions. However, they will be able to transmit written questions to the faculty.
Who should attend ?
Attendees include industry representatives with interest in clinical trials, product development, market access, guidelines development and implementation, patients’ advocacy specialists, clinical research organizations and payers.
Registration price list
Contact
Contact us to finalize your participation as sponsor (For individual attendees’ registration contact TMA)
Grant Opportunities (including CME, Advisory Boards & Customized Grants)
Fabrice Poller
Tel.: + 33 (0) 6 99 66 19 73
E-mail: fpoller@tmacademy.org
WHY ATTEND THE HFGF?
Guidelines increasingly shape clinical practice. Their development and implementation is a critical issue for all stakeholders interested in better patients outcomes.
A better understanding of the processes involved in guidelines development will help companies that develop drugs, biomarkers, and devices to adapt and improve their research and development programmes for the future.
This could also translate into earlier and more efficient development of diagnostic and therapeutic tools for patients.
PRACTICAL DISCUSSIONS
How do guideliners deal with the available evidence and what are their expectations in this respect? What criteria must a product or an intervention meet to be recommended by heart failure guidelines? What are the most frequent reasons for failure? Why may guidelines of geographically distinct origins but dealing with the same evidence occasionally reach different conclusions? What should be done to avoid that guidelines being lost in translation? How can we adapt the guidelines for low and middle income countries?
EDUCATIONAL OBJECTIVES
- Better understand the guideline development process.
- Review the latest scienfific evidence regarding drugs, devices and biomarkers
- Analyse the latest hot topics regarding guidelines and their implications in clinical practice.
- Design studies and plan analyses for future trials
A SOURCE OF INSPIRATION FOR FURTHER RESEARCH AND DEVELOPMENT
OBJECTIVE
to better understand the Heart Failure guidelines development process and its implications.
FORMAT
A series of short presentations and discussions with a focus on practical examples, case studies and interactivity between Faculty members.
PARTICIPANTS
Multidisciplinary panel of leading international experts with guideline-making experience.
ACADEMIC
The format is strictly academic with discussions among experts. Participants can transmit written questions during the program and participate in ad hoc discussions at the end of each day.
DISCUSSION TOPICS
Latest trial evidence, ongoing research and controversial issues that have implications for the development of clinical practice guidelines;
EXPERT PANEL
Speakers and discussants who will address these topics have been selected from among the top-level North American and international experts in cardiology who participate in the regular update of guidelines.
ASK FOR MORE INFORMATION
Organized by
